Dr. Hönle AG (HNL) — Capital Reinvestment Ratio
Latest as of September 2025:
0.16x
Dr. Hönle AG (HNL) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (€2.96 Million) in capital expenditures (€469.00K). See Dr. Hönle AG free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.16x
Capex / Operating Cash Flow
Operating Cash Flow
€2.96 Million
EUR
Capital Expenditures
€469.00K
EUR
Data as of
Sep 2025
Most recent filing
Dr. Hönle AG Capital Reinvestment Ratio (2014–2025)
This chart tracks Dr. Hönle AG's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Dr. Hönle AG (2014–2025)
Year-by-year Capital Reinvestment Ratio for Dr. Hönle AG from 2014 to 2025. For live market cap and broader valuation context, see HNL stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | €4.99 Million | €1.90 Million | ▲ +0.5% |
| 2024 | 0.38x | €5.53 Million | €2.09 Million | ▼ -59.4% |
| 2023 | 0.93x | €3.14 Million | €2.93 Million | ▼ -93.8% |
| 2021 | 15.12x | €1.13 Million | €17.09 Million | ▲ +262.3% |
| 2020 | 4.17x | €7.23 Million | €30.20 Million | ▲ +266.5% |
| 2019 | 1.14x | €16.92 Million | €19.28 Million | ▲ +160.8% |
| 2018 | 0.44x | €24.22 Million | €10.58 Million | ▼ -46.4% |
| 2017 | 0.81x | €6.58 Million | €5.36 Million | ▲ +41.3% |
| 2016 | 0.58x | €8.63 Million | €4.98 Million | ▲ +147.3% |
| 2015 | 0.23x | €9.16 Million | €2.14 Million | ▼ -43.4% |
| 2014 | 0.41x | €7.49 Million | €3.08 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow